Hyaluronic acid reagent functional chitosan-PEI conjugate with AQP2-siRNA suppressed endometriotic lesion formation

Código QR

Hyaluronic acid reagent functional chitosan-PEI conjugate with AQP2-siRNA suppressed endometriotic lesion formation

Meng-Dan Zhao,1 Jin-Lin Cheng,2 Jing-Jing Yan,1 Feng-Ying Chen,1 Jian-Zhong Sheng,3 Dong-Li Sun,1 Jian Chen,4 Jing Miao,4 Run-Ju Zhang,1 Cai-Hong Zheng,1 He-Feng Huang1,5 1Women’s Hospital, School of Medicine, Zhejiang University, Hangzhou, 2State Key Laboratory for Diagnosis and Treatmen...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Zhao MD, Cheng JL, Yan JJ, Chen FY, Sheng JZ, Sun DL, Chen J, Miao J, Zhang RJ, Zheng CH, Huang HF
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2016
Materias:	chitosan-PEI Hyaluronic acid AQP2-siRNA endometriosis targeted therapy Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/5b13104b0acb4b9299a9f133e4277249
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Antitumor effect of hyaluronic-acid-modified chitosan nanoparticles loaded with siRNA for targeted therapy for non-small cell lung cancer
por: Zhang W, et al.
Publicado: (2019)

siRNA-loaded selenium nanoparticle modified with hyaluronic acid for enhanced hepatocellular carcinoma therapy
por: Xia Y, et al.
Publicado: (2018)

Superparamagnetic iron oxide nanoparticles modified with polyethylenimine and galactose for siRNA targeted delivery in hepatocellular carcinoma therapy
por: Yang Z, et al.
Publicado: (2018)

In vivo therapeutic efficacy of TNFα silencing by folate-PEG-chitosan-DEAE/siRNA nanoparticles in arthritic mice
por: Shi Q, et al.
Publicado: (2018)

Nanoscale polysaccharide derivative as an AEG-1 siRNA carrier for effective osteosarcoma therapy
por: Wang F, et al.
Publicado: (2018)

Nucleic Acid-Based Treatments Against COVID-19: Potential Efficacy of Aptamers and siRNAs
por: Javad Khanali, et al.
Publicado: (2021)

Chitosan-based nanoparticles for survivin targeted siRNA delivery in breast tumor therapy and preventing its metastasis
por: Sun P, et al.
Publicado: (2016)

Immunohistochemical Identification of AQP1 in Livers of the High-fat Diet Rats
por: Wang,Jinbao, et al.
Publicado: (2019)

Stimuli-responsive hybrid nanocarriers developed by controllable integration of hyperbranched PEI with mesoporous silica nanoparticles for sustained intracellular siRNA delivery
por: Prabhakar N, et al.
Publicado: (2016)

Liposomal codelivery of an SN38 prodrug and a survivin siRNA for tumor therapy
por: Bi Y, et al.
Publicado: (2018)

The therapeutic effect in gliomas of nanobubbles carrying siRNA combined with ultrasound-targeted destruction
por: Cai W, et al.
Publicado: (2018)

Renal Expression of AQP1 in the High-fat Nutritional Obesity of Rat
por: Wang,Jinbao, et al.
Publicado: (2019)

Insights into the therapeutic potential of hypoxia-inducible factor-1α small interfering RNA in malignant melanoma delivered via folate-decorated cationic liposomes
por: Chen Z, et al.
Publicado: (2016)

Expression of V2R and AQPs in the Renal Medulla of High-fat Nutritional Obesity of Rat
por: Wang,Jinbao, et al.
Publicado: (2019)

Quick synthesis of a novel combinatorial delivery system of siRNA and doxorubicin for a synergistic anticancer effect
por: Chen M, et al.
Publicado: (2019)

Small interfering RNAs (siRNAs) in cancer therapy: a nano-based approach
por: Mahmoodi Chalbatani G, et al.
Publicado: (2019)

Lyophilization and stability of antibody-conjugated mesoporous silica nanoparticle with cationic polymer and PEG for siRNA delivery
por: Ngamcherdtrakul W, et al.
Publicado: (2018)

pH-responsive hybrid nanoparticle with enhanced dissociation characteristic for siRNA delivery
por: Shi M, et al.
Publicado: (2018)

Expression of Aquaporin 2, Aquaporin 3 and Aquaporin 4 in Renal Medulla of Bactrian Camel ( Camelus bactrianus )
por: Wang,Jinbao, et al.
Publicado: (2018)

Targeting cell cycle protein in gastric cancer with CDC20siRNA and anticancer drugs (doxorubicin and quercetin) co-loaded cationic PEGylated nanoniosomes
por: Hemati M, et al.
Publicado: (2019)

Characterization of a Gelatin/Chitosan/Hyaluronan scaffold-polymer
por: Enrione,Javier, et al.
Publicado: (2010)

VEGF siRNA delivered by polycation liposome-encapsulated calcium phosphate nanoparticles for tumor angiogenesis inhibition in breast cancer
por: Chen J, et al.
Publicado: (2017)

A Lipid-Coated Nanoconstruct Composed of Gold Nanoparticles Noncovalently Coated with Small Interfering RNA: Preparation, Purification and Characterization
por: Anna V. Epanchintseva, et al.
Publicado: (2021)

Effect of the nanoformulation of siRNA-lipid assemblies on their cellular uptake and immune stimulation
por: Kubota K, et al.
Publicado: (2017)

Novel functionalized nanoparticles for tumor-targeting co-delivery of doxorubicin and siRNA to enhance cancer therapy
por: Xia Y, et al.
Publicado: (2017)

Efficient delivery of Notch1 siRNA to SKOV3 cells by cationic cholesterol derivative-based liposome
por: Zhao Y, et al.
Publicado: (2016)

Multifunctional selenium nanoparticles as carriers of HSP70 siRNA to induce apoptosis of HepG2 cells
por: Li Y, et al.
Publicado: (2016)

GE11 peptide-conjugated nanoliposomes to enhance the combinational therapeutic efficacy of docetaxel and siRNA in laryngeal cancers
por: Xu WW, et al.
Publicado: (2017)

Efficient miRNA Inhibitor with GO-PEI Nanosheets for Osteosarcoma Suppression by Targeting PTEN
por: Ou L, et al.
Publicado: (2020)

Enhancing siRNA-based cancer therapy using a new pH-responsive activatable cell-penetrating peptide-modified liposomal system
por: Xiang B, et al.
Publicado: (2017)

Hypoxia-responsive ionizable liposome delivery siRNA for glioma therapy
por: Liu HM, et al.
Publicado: (2017)

Anti-EpCAM functionalized graphene oxide vector for tumor targeted siRNA delivery and cancer therapy
por: Si Chen, et al.
Publicado: (2021)

Echogenic PEGylated PEI-Loaded Microbubble As Efficient Gene Delivery System
por: Liufu C, et al.
Publicado: (2019)

Tumor-specific delivery of therapeutic siRNAs by anti-EGFR immunonanoparticles
por: Kim JS, et al.
Publicado: (2018)

Smart polymeric nanoparticles with pH-responsive and PEG-detachable properties for co-delivering paclitaxel and survivin siRNA to enhance antitumor outcomes
por: Jin M, et al.
Publicado: (2018)

Integrin-β1, not integrin-β5, mediates osteoblastic differentiation and ECM formation promoted by mechanical tensile strain
por: Zeng,Qiangcheng, et al.
Publicado: (2015)

Effects of c-FLIPL Knockdown in Cervical Uterine Carcinoma Cell Lines
por: Ili,Carmen G, et al.
Publicado: (2015)

Reductive nanocomplex encapsulation of cRGD-siRNA conjugates for enhanced targeting to cancer cells
por: Zhou Z, et al.
Publicado: (2017)

Inhibition of cell proliferation through an ATP-responsive co-delivery system of doxorubicin and Bcl-2 siRNA
por: Zhang J, et al.
Publicado: (2017)

Doxorubicin and anti-VEGF siRNA co-delivery via nano-graphene oxide for enhanced cancer therapy in vitro and in vivo
por: Sun Q, et al.
Publicado: (2018)